Metastatic Castration-resistant Prostate Cancer, MCRPC: 332 Clinical Trials, Page 1 of 34

1 2 3 4 5 …10 15 20 … »Last Page »

Hide Studies Not Open or Pending

A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide

Condition(s):Metastatic Castration-resistant Prostate Cancer (mCRPC)Last Updated:December 9, 2020Completed

European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:May 1, 2019Completed

EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)

Condition(s):Metastatic Castration Resistant Prostate Cancer (mCRPC)Last Updated:January 15, 2021Active, not recruiting

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:December 11, 2020Recruiting

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:November 24, 2020Not yet recruiting

A Phase III Study of Fluzoparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Condition(s):Metastatic Castration-Resistant Prostate Cancer (mCRPC)Last Updated:December 31, 2020Not yet recruiting

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Condition(s):Prostate Neoplasms; Prostate CancerLast Updated:March 21, 2018Completed

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:August 19, 2019Completed

A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Condition(s):Prostatic NeoplasmsLast Updated:February 8, 2017Withdrawn

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:January 20, 2021Active, not recruiting

1 2 3 4 5 …10 15 20 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.